© PR Newswire
04.12.2025
INSM
LISTED
NASDAQ
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
News Preview
BRIDGEWATER, N.J., Dec. 4, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced the granting of inducement awards to 92 new employees. The awards were granted under t...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
ACON
LISTED
NASDAQ
Aclarion Announces Publication of Nociscan Article in Special Pain Issue of the International Journal of Spine Surgery (IJSS)
News Preview
Aclarion Announces Publication of Nociscan Article in Special Pain Issue of the International Journal of Spine Surgery (IJSS)...
Themefolio
Profiler
Peergroup
© Newsfile
04.12.2025
PREV
LISTED
CSE
PreveCeutical Announces Grant of Patent for Innovative Pain Therapy Technology
News Preview
Vancouver, British Columbia--(Newsfile Corp. - December 4, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCID: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") is pleased to announce that the Australian Patent Office has granted Australian Patent No. AU2020212659, titled "A Cyclic Peptide", which relates to the Company's pai...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Newsfile
04.12.2025
MUSL
LISTED
CSE
Rejuvenate Muscle Health Wins Prestigious "Best Drink" Award at 2025 ECRM Vitamin, Weight Management & Sports Nutrition Session
News Preview
Voted Best Drink by leading U.S. and Canadian retail buyers in a head-to-head taste test against 30+ top CPG brandsAvailable in over 8,000 retail locations plus Top 100 Protein Drink status on Amazon.comAward-winning taste to launch in Ready-to-Drink (RTD) format in Q3 2026, targeting the high-growth functional beverage marketBurlington, Ontario--(...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
04.12.2025
CGC
LISTED
NASDAQ
Canopy Growth Launches Claybourne Gassers Liquid Diamonds All-In-One Vapes in Canada, Expanding Footprint in High-Growth Vape Segment
News Preview
Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, today announced the national launch of Claybourne Gassers, a new lineup of All-in-One (AIO) vapes featuring liquid diamonds. The launch marks Claybourne’s entry int...
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2025
HIMS
LISTED
NYSE
Hims & Hers Continues Major International Expansion With Official Entry Into Canada
News Preview
Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform in the United States, is now serving customers in Canada. This entry follows the recent completion of Hims & Hers’ acquisition of Livewell, a trusted Canadian digital health platform offering access to a variety of treatments, with a focus on weight loss. Build...
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2025
PODD
LISTED
NASDAQ
Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced it has received FDA 510(k) clearance for significant enhancements to the Omnipod 5 Automated Insulin Delivery System. These updates to the Omnipod 5 algorithm set a new benchmark in...
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2025
HIMS
LISTED
NYSE
Hims & Hers Now Serving Customers in Canada
News Preview
Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform in the United States, is now serving customers in Canada. This entry follows the recent acquisition of Livewell, a trusted Canadian digital health platform focused on weight loss. Through this expansion, Hims & Hers is well-positioned to usher in the next era o...
Themefolio
Profiler
Peergroup
© PR Newswire
04.12.2025
BDX
LISTED
NYSE
BD and ChemoGLO™ Collaborate to Expand Hazardous Drug Contamination Testing for Health Care Facilities and Laboratories
News Preview
FRANKLIN LAKES, N.J., Dec. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and ChemoGLO™, a specialist in hazardous drug detection and decontamination, today announced a strategic collaboration to advance hazardous drug contamination testing in health care settings to improve the...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
TLRY
LISTED
TSX
Tilray Releases the Ultimate 2025 Holiday Drink Gift Guide, Celebrating Seasonal Sips and Moments of Connection from Coast to Coast
News Preview
ATLANTA, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc., company (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, is pleased to unveil the Ultimate 2025 Holiday Drink Gift Guide—a curated collection of the season’s most giftable...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
PLRX
LISTED
NASDAQ
Pliant Therapeutics Announces Interim Data from PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors
News Preview
One complete response and three partial responses observed in heavily pretreated ICI-secondary refractory patients in high dose cohorts...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
RPRX
LISTED
NASDAQ
Royalty Pharma and Denali Therapeutics Announce $275 Million Royalty Funding Agreement
News Preview
NEW YORK and SOUTH SAN FRANCISCO, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) and Denali Therapeutics, Inc. (Nasdaq: DNLI) today announced a $275 million synthetic royalty funding agreement based on future net sales of tividenofusp alfa....
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
04.12.2025
QURE
LISTED
NASDAQ
uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease
News Preview
LEXINGTON, Mass. and AMSTERDAM, Dec. 04, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that the company received final meeting minutes from the U.S. Food and Drug Administration (FDA) regarding a pre-Biologics License...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
MPLT
LISTED
NASDAQ
MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress
News Preview
SAN FRANCISCO and BOSTON, Dec. 04, 2025 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT), a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders, today reported financial results for the third quarter of 2025 and highlighted recent progress a...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
FTRE
LISTED
NASDAQ
SCTbio and Fortrea Forge Strategic Collaboration to Accelerate Cell and Gene Therapy Development and Delivery
News Preview
PRAGUE, Czech Republic and DURHAM, N.C., Dec. 04, 2025 (GLOBE NEWSWIRE) -- SCTbio, a leading European CDMO specializing in GMP manufacturing for cell-based products, and Fortrea, a leading global contract research organization (CRO), today announced a strategic collaboration agreement between the two companies. This partnership aims to streamline...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
DNLI
LISTED
NASDAQ
Denali Therapeutics and Royalty Pharma Announce $275 Million Royalty Funding Agreement
News Preview
SOUTH SAN FRANCISCO, Calif. and NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) and Royalty Pharma plc (Nasdaq: RPRX) today announced a $275 million synthetic royalty funding agreement based on future net sales of tividenofusp alfa....
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
TLRY
LISTED
TSX
2025 Cannabis Holiday Gift Guide Highlights Canada’s Most Popular Cannabis Products for the Holiday Season
News Preview
TORONTO, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc., company (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today released its 2025 Cannabis Holiday Gift Guide, showcasing Canadians’ top picks for gifting, entertaining, an...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
BCRX
LISTED
NASDAQ
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
RESEARCH TRIANGLE PARK, N.C., Dec. 04, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted four newly-hired employees stock options to purchase an aggregate of 57,100 shares, and restricted stock units (RSUs) covering an aggregate of 46,400...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
PTHS
LISTED
XASE
Pelthos Therapeutics Signs Major Pharmacy Benefit Manager Agreement Expanding Patient Access to ZELSUVMI™ (berdazimer) Topical Gel, 10.3%
News Preview
ZELSUVMI is the first and only FDA-approved at-home treatment for molluscum contagiosum, a highly contagious viral skin condition affecting an estimated 16.7 million people, with up to 6 million new incidents reported every year in the United States...
Themefolio
Profiler
Peergroup
© Newsfile
04.12.2025
HBFG
LISTED
CSE
Happy Belly Food Group's Rosie's Burgers QSR Announces the Signing of a Franchise Agreement and Secured Real Estate for Whitby, Ontario
News Preview
Toronto, Ontario--(Newsfile Corp. - December 4, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leading consolidator of emerging food brands is pleased to announce that a franchise agreement has been signed and a prime real estate location has been secured for a new Rosie's Burgers ("Rosie's") rest...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
CBIO
LISTED
NASDAQ
Crescent Biopharma Announces Transformational Partnership with Kelun-Biotech and $185 Million Private Placement, Accelerating and Expanding Global Pipeline of Next Generation Therapeutics for Solid Tumors
News Preview
Partnership with Kelun-Biotech expands pipeline and accelerates combination strategy with CR-001, a PD-1 x VEGF bispecific antibody, and multiple antibody-drug conjugates (ADCs), generating clinical data in global markets and Greater China...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
CBIO
LISTED
NASDAQ
Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics
News Preview
Companies to advance CR-001, a PD-1 x VEGF bispecific antibody, and SKB105, an integrin beta-6-directed antibody-drug conjugate (ADC), in global markets and China...
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2025
PLTR
LISTED
NASDAQ
Palantir Launches Chain Reaction to Build American AI Infrastructure; Founding Partners Include CenterPoint Energy and NVIDIA
News Preview
Palantir Technologies Inc. (NASDAQ: PLTR) today unveiled Chain Reaction, the operating system for American AI infrastructure.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251204391468/en/
The bottleneck to AI innovation is no longer algorithms; it is power and compute. America is at a...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
SAN
LISTED
EURONEXT
Press Release: Sanofi completes acquisition of Vicebio
News Preview
...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
04.12.2025
MDCE
LISTED
OTC
Medical Care Technologies Inc. (OTC Pink:MDCE) Builds on Subsidiary Revenue Strength to Accelerate AI Health-Tech Mission in 2026
News Preview
MESA, ARIZONA / ACCESS Newswire / December 4, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced a strategic acceleration of its core mission in artificial intelligence-driven health and wellness technology. With Infinite Auctions (www.infiniteauctions.com) operating since 2016 and Real Game Used (www.realgameused.com) since 2017...
Themefolio
Profiler
Peergroup
© Newsfile
04.12.2025
DTC
LISTED
CSE
Defence Therapeutics Announces Formation of Scientific Advisory Board to Guide Advancement of Accum-Enhanced Antibody Drug Conjugate Programs
News Preview
Montreal, Quebec--(Newsfile Corp. - December 4, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a biotechnology company advancing a proprietary intracellular delivery platform that enables more potent, safer, and more effective antibody-based and radiotherapeutic treatments, is pleased...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
04.12.2025
ASBP
LISTED
NASDAQ
Aspire Biopharma Provides Q3 2025 Business Update
News Preview
ESTERO, FL / ACCESS Newswire / December 4, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, today provides a business update for the quarter ended September 30, 2025.Q3 2025 and Recent HighlightsExpanded its scientific team w...
Themefolio
Profiler
Peergroup
© PR Newswire
04.12.2025
SECT_B
LISTED
STO
Swedish health care region expands with Sectra and digitizes pathology for advanced cancer care
News Preview
LINKÖPING, Sweden, Dec. 4, 2025 /PRNewswire/ -- The Swedish healthcare provider Region Halland will expand its use of international medical imaging IT and cybersecurity company Sectra's (STO: SECT B) solutions by adding digital pathology. Replacing microscopes with a digital workflow will provide them with instant remote access to images, facilita...
Themefolio
Profiler
Peergroup
© PR Newswire
04.12.2025
VEEV
LISTED
NYSE
Veeva AI Agents jetzt verfügbar, um Produktivität und Kundenorientierung zu steigern
News Preview
Veeva AI liefert branchenspezifische KI für das nächste Kapitel der Life SciencesPLEASANTON, Kalifornien, 4. Dezember 2025 /PRNewswire/ --Ein wichtiger Meilenstein für Veeva AI, die branchenspezifische KI für Life Sciences: Veeva Systems (NYSE: VEEV) hat heute bekannt gegeben, dass Veeva AI Agents jetzt für Vault CRM und PromoMats verfügbar ist. D...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
04.12.2025
FWBI
LISTED
NASDAQ
GridAI Technologies Corp. Announces Appointment of Marshall Chapin as Chief Executive Officer of wholly-owned operating subsidiary GridAI, Inc
News Preview
BOCA RATON, FL / ACCESS Newswire / December 4, 2025 / GridAI Technologies Corp (NASDAQ:GRDX) ("GridAI" or the "Company") today announced the appointment of Marshall Chapin as Chief Executive Officer of its energy-orchestration operating subsidiary developing next-generation grid and power-management software for hyperscale artif...
Themefolio
Profiler
Peergroup
© PR Newswire
04.12.2025
SOBI
LISTED
STO
The New England Journal of Medicine Publishes Positive Phase 3 VALIANT Results of pegcetacoplan for C3G and Primary IC-MPGN
News Preview
Robust and clinically meaningful benefits observed across all three key markers of disease – 68% reduction in proteinuria, stabilisation of kidney function, and substantial clearance of C3 deposits. Consistent results across C3G and primary IC-MPGN, adults and adolescents, and native and post-transplant kidney disease. Pegcetacoplan is under regul...
Themefolio
Profiler
Peergroup
© EQS Newswire
04.12.2025
EVT
LISTED
XETR
Evotec-partner Bayer starts Phase 2 study for treatment of patients with Alport syndrome
News Preview
Phase 2 clinical trial initiated to evaluate SEMA3A mAb as potential treatment for Alport syndrome
Milestone payment to Evotec expected upon first dosing of first study participant in early 2026
Hamburg, Germany, 04 December 2025:
Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 56......
Themefolio
Profiler
Peergroup
© EQS Newswire
04.12.2025
EVT
LISTED
XETR
Evotec-Partner Bayer startet Phase-2-Studie zur Behandlung von Patienten mit Alport-Syndrom
News Preview
Klinische Studie der Phase 2 begonnen, um das Potenzial eines SEMA3A-Antikörpers als mögliche Behandlung für das Alport-Syndrom zu bewerten
Meilensteinzahlung an Evotec nach erster Verabreichung der Prüfsubstanz an den ersten Studienteilnehmenden für Anfang 2026 erwartet
Hamburg, 04. Dezember 2025:
Evotec SE (Frankfurter Wertpapierbör......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
04.12.2025
TNON
LISTED
NASDAQ
Tenon Medical Announces Successful Completion of Initial Cases with New SImmetry(R)+ SI Joint Fusion System
News Preview
~ Procedures Completed in Various Spine Centers of Excellence Throughout the Country Including Florida, Arizona, Ohio, and Texas ~~ SImmetry+ combines 3D-printed titanium implants, a robust joint decorticator, and a streamlined bone graft delivery system to offer treatment solutions aligned with established fusion principles ~~ Immediate revenue im...
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2025
BAYN
LISTED
XETR
Bayer Starts Phase IIa Study for Treatment of Patients With Alport Syndrome
News Preview
Bayer announced today initiation of a Phase IIa clinical trial with BAY 3401016, an investigational monoclonal antibody with potential to block a protein called Semaphorin 3A (Sema3A), which is thought to be involved in the progression of kidney damage in Alport Syndrome (AS), a rare genetic disorder. The first-in-patient study, ASSESS, is a rando...
Themefolio
Profiler
Peergroup
© PR Newswire
04.12.2025
BIOA B
LISTED
STO
New Leqembi-data presented at CTAD 2025 suggests potential to delay disease progression by up to 8.3 years with continued treatment
News Preview
STOCKHOLM, Dec. 4, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai presented the latest findings on time saved with continued treatment with lecanemab (Leqembi®) at the 18th Clinical Trials in Alzheimer's Disease (CTAD) conference, held in San Diego December 1-4. Data suggests potential to delay disease progress...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
04.12.2025
VSEE
LISTED
NASDAQ
VSee and Novant Health Urgent Care Share Blueprint for Scalable, Profitable Tele-Urgent Programs
News Preview
VSee Health AI telehealth technology leader highlights client success and growing market momentum in virtual care SAN JOSE, CALIFORNIA / ACCESS Newswire / December 4, 2025 / VSee Health, Inc. (Nasdaq:VSEE), a leading provider of AI telehealth technology solutions, announces an upcoming webinar today with Novant Health Urgent Care, the largest urgen...
Themefolio
Profiler
Peergroup
© PR Newswire
04.12.2025
BIOA B
LISTED
STO
New Leqembi-data presented at CTAD 2025 suggests potential to delay disease progression by up to 8.3 years with continued treatment
News Preview
STOCKHOLM, Dec. 4, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai presented the latest findings on time saved with continued treatment with lecanemab (Leqembi®) at the 18th Clinical Trials in Alzheimer's Disease (CTAD) conference, held in San Diego December 1-4. Data suggests potential to delay disease progress...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
04.12.2025
DRMA
LISTED
NASDAQ
A New Realm of Skincare is Coming: Dermata Teases New OTC Brand Identity
News Preview
SAN DIEGO, CA / ACCESS Newswire / December 4, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata" or the "Company"), a science-driven leader in dermatologic solutions, today announced that it will soon reveal its new brand name for its over-the-counter ("OTC") skincare business representing its evo...
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2025
GALD
LISTED
XWSX
Galderma Secures ‘BBB’ Credit Rating With Positive Outlook from S&P Global Ratings
News Preview
Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that S&P Global Ratings (S&P) has assigned the company a ‘BBB’ long-term issuer credit rating with a positive outlook.
The rating reflects Galderma’s strong track record of growth and its leading positions across Injectable Aesthetics, Dermatological...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
AGFB
LISTED
EURONEXT
Agfa announces additional measures to adjust the cost base of its traditional film activities to the reality in the market
News Preview
December 4, 2025 – 7:45 a.m. CET Regulated information...
Themefolio
Profiler
Peergroup
© EQS Newswire
04.12.2025
FYB
LISTED
XETR
Formycon and MS Pharma sign exclusive commercialization partnership for Keytruda® biosimilar candidate FYB206 for the MENA Region
News Preview
Presse Release // December 04, 2025
Formycon and MS Pharma sign exclusive commercialization partnership for Keytruda® biosimilar candidate FYB206 for the MENA Region
Planegg-Martinsried, Germany / Amman, Jordan – Formycon AG (FSE: FYB, Prime Standard) and MS Pharma jointly announce that they have entered into an exclusive licensing and suppl......
Themefolio
Profiler
Peergroup
© EQS Newswire
04.12.2025
FYB
LISTED
XETR
Formycon und MS Pharma schließen exklusive Kommerzialisierungspartnerschaft für den Keytruda®-Biosimilar-Kandidaten FYB206 in der MENA-Region
News Preview
Pressemitteilung // 04. Dezember 2025
Formycon und MS Pharma schließen exklusive Kommerzialisierungspartnerschaft für den Keytruda®-Biosimilar-Kandidaten FYB206 in der MENA-Region
Planegg-Martinsried, Deutschland / Amman, Jordanien – Die Formycon AG (FWB: FYB, Prime Standard) und MS Pharma geben gemeinsam bekannt, dass sie eine exklusive Lizenz- ......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
04.12.2025
ZOM
LISTED
XASE
Zomedica Expands TRUFORMA(R) Diagnostic Menu with Launch of Equine Progesterone Assay
News Preview
Newest assay expands TRUFORMA market opportunity by building on endocrinology foundation to address reproductive health in the equine segment ANN ARBOR, MI / ACCESS Newswire / December 4, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and t...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
04.12.2025
WGRX
LISTED
NASDAQ
Wellgistics Health Announces that it will Distribute a Dream Bowl 2026 Meme Coin to Wellgistics Health Stockholders
News Preview
TAMPA, FLORIDA / ACCESS Newswire / December 4, 2025 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader implementing EinsteinRx™ artificial intelligence prescription drug routing into blockchain-enabled smart contracts platform PharmacyChain™ to optimize the prescription medicines r...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
TECN
LISTED
SIX
Changes to Tecan’s Board of Directors proposed to shareholders at the upcoming Annual General Meeting 2026
News Preview
Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
ADXN
LISTED
SIX
Addex Therapeutics Reports 2025 Third Quarter Financial Results and Provides Corporate Update
News Preview
Ad Hoc Announcement Pursuant to Art. 53 LR...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
04.12.2025
EVT
LISTED
XETR
Evotec-Partner Bayer Starts Phase 2 Study for Treatment of Patients with Alport Syndrome
News Preview
Phase 2 clinical trial initiated to evaluate SEMA3A mAb as potential treatment for Alport syndromeMilestone payment to Evotec expected upon first dosing of first study participant in early 2026 HAMBURG, DE / ACCESS Newswire / December 4, 2025 / Evotec SE (Frankfurt Stock Exchange:EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NAS...
Themefolio
Profiler
Peergroup
© PR Newswire
04.12.2025
VEEV
LISTED
NYSE
Veeva AI Agents Now Available to Increase Productivity and Customer Centricity
News Preview
Veeva AI delivers industry-specific AI for the next chapter in life sciencesSINGAPORE, Dec. 4, 2025 /PRNewswire/ -- In a major milestone for Veeva AI, industry-specific AI for life sciences, Veeva Systems (NYSE: VEEV) today announced the availability of Veeva AI Agents for Vault CRM and PromoMats. Veeva AI in the Veeva Vault Platform and deep, spe...
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2025
AVXL
LISTED
NASDAQ
AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Anavex Life Sciences Corp. (“Anavex” or “the Company”) (NASDAQ: AVXL) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or faile...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
AXGN
LISTED
NASDAQ
Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx)
News Preview
ALACHUA, Fla. and TAMPA, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical technologies for the restoration of peripheral nerve function, today announced that the U.S. Food and Drug Administration (the “FDA”) has approved the Biologics License Application (“BLA”) f...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
IMAB
LISTED
NASDAQ
NovaBridge Announces Presentation of Ragistomig Expanded Phase 1 Data at ESMO-IO
News Preview
ROCKVILLE, Md., Dec. 03, 2025 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge or the Company) a global biotechnology platform company committed to accelerating access to innovative medicines, today announced that new data from the expanded Phase 1 dosing study for ragistomig, a 4-1BB X PD-L1 bispecific antibody, will be prese...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
RGNT
LISTED
XASE
Regentis Biomaterials Ltd. Announces Pricing of Initial Public Offering
News Preview
Herzliya, Israel, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Regentis Biomaterials Ltd. (NYSE American: RGNT) (“Regentis”, or the “Company”), a regenerative medicine company dedicated to developing innovative tissue repair solutions that seek to restore the health and enhance the quality of life of patients, today announced the pricing of its initial pub...
Themefolio
Profiler
Peergroup
© PR Newswire
04.12.2025
45230
LISTED
XJPX
Eisai Presents New Data on the Continued and Expanding Benefit of LEQEMBI® (lecanemab-irmb) Maintenance Treatment in Early Alzheimer's Disease at the Clinical Trials on Alzheimer's Disease (CTAD) Conference 2025
News Preview
Long-term LEQEMBI treatment suggests potential to delay disease progression from Mild Cognitive Impairment (MCI) to moderate Alzheimer's disease by up to 8.3 years in low-amyloid group who started treatment at an early stageNew safety and efficacy data presented at scientific symposium on subcutaneous formulation for LEQEMBI initiation treatment,...
Themefolio
Profiler
Peergroup
© BusinessWire
03.12.2025
ACHC
LISTED
NASDAQ
Acadia Healthcare Company, Inc. (ACHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
News Preview
Law Offices of Howard G. Smith announces an investigation on behalf of Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ACADIA HEALTHCARE COMPANY, INC. (ACHC), CONTACT THE LAW OFFICES OF HOWARD...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.12.2025
BIIB
LISTED
NASDAQ
Eisai Presents New Data on the Continued and Expanding Benefit of LEQEMBI® (lecanemab-irmb) Maintenance Treatment in Early Alzheimer’s Disease at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference 2025
News Preview
Long-term LEQEMBI treatment suggests potential to delay disease progression from Mild Cognitive Impairment (MCI) to moderate Alzheimer’s disease by up to 8.3 years in low-amyloid group who started treatment at an early stage...
Themefolio
Profiler
Peergroup
© Newsfile
03.12.2025
MYTC
LISTED
CSE
MyndTec Inc. Completes Eighth Tranche of Non-Brokered Private Placement
News Preview
Mississauga, Ontario--(Newsfile Corp. - December 3, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), a neurological treatment and rehabilitation medical technology company, is pleased to announce that it has closed the eighth tranche of its non-brokered private placement previously announced on January 30, 2025 (the "Offering")....
Themefolio
Profiler
Peergroup
© Globe Newswire
03.12.2025
MLAB
LISTED
NASDAQ
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 3, 2026
News Preview
LAKEWOOD, Colo., Dec. 03, 2025 (GLOBE NEWSWIRE) -- - Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the third quarter of fiscal year 2026 at approximately 8:00 A.M. Eastern Time (ET) on Tuesday, February 3, 2026....
Themefolio
Profiler
Peergroup
© PR Newswire
03.12.2025
MDT
LISTED
NYSE
Medtronic announces FDA clearance of Hugo™ robotic-assisted surgery system for urologic surgical procedures
News Preview
Hugo RAS system brings choice to the U.S., coupled with the full suite of Medtronic surgical offerings, ultimately creating a connected and integrated operating room today and into the future.GALWAY, Ireland, Dec. 3, 2025 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in surgical innovation, today announced the U.S. Food and Drug Administr...
Themefolio
Profiler
Peergroup
© BusinessWire
03.12.2025
INCY
LISTED
NASDAQ
Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Incyte Corporation (Nasdaq: INCY) announced today equity inducement awards grants to Richard Hoffman, Company’s new Executive Vice President and General Counsel, pursuant to the Company’s 2024 Inducement Stock Incentive Plan. The awards were approved by the compensation committee of the Company’s Board of Directors as an inducement material to the...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
